CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit
LARRY DELISLE BREAKS SILENCE 25 YEARS AFTER DRIVING KIDS INTO DETROIT RIVER - READ MORE

clinical trial

adeona

Adeona’s Multiple Sclerosis Trial Receives $409,426 Grant

Ann Arbor-based Adeona Pharmaceuticals Inc. said Monday that the ongoing clinical trial of its Trimesta drug candidate has received an additional $409,426 in grant funding from the National Multiple Sclerosis Society.

03/28/2011

AP PHOTO -- DO NOT USE

Cerenis Initiates Phase 2 Study of Coronary Syndrome Treatment

Cerenis Therapeutics, the pharma startup with offices in Toulouse, France and Portage, Tuesday announced the start of a Phase 2 clinical trial of its lead drug candidate, CER-001, in patients with acute coronary syndrome.

03/15/2011

esperion

Esperion Starts Phase 2 Trial Of Cholesterol Buster

The Plymouth pharmaceutical developer Esperion Therapeutics Thursday announced that it has initiated a Phase 2 clinical study for ETC-1002, the company’s lead product candidate.  ETC-1002 is a novel small molecule compound that has demonstrated preclinical […]

01/06/2011

Adeona Completes Enrollment In Alzheimer's Study

Ann Arbor-based Adeona Pharmaceuticals Inc., (Amex: AEN) Wednesday announced completion of 100 percent enrollment in Part 2 of its clinical study, “A Prospective, Randomized, Double Blind Trial of a Novel Oral Zinc Cysteine Preparation in […]

10/06/2010

Stem Cell Cures On Horizon, UM Scientists Say

Stem cell skeptics have been asking for years, where are the cures? Well, stick around. Spectacular cures may be coming soon, and they have a University of Michigan connection.

10/04/2010

previous